Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-06-17

FDA Approved: PREZISTA — Supplemental Application (Janssen Products LP)

View source ↗

Summary

The FDA approved a supplemental application for Prezista (darunavir) submitted by Janssen Products LP. The approval updates the drug's labeling based on the sub…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREZISTA (darunavir)

Snippet

SUPPL AP for PREZISTA (DARUNAVIR)